TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
NVAX

Novavax Inc

Healthcare · Biotechnology

10.60$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 956 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NVAX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,657 1,797 1,354 1,819 1,712 1,560 1,293 1,337 1,180 1,177 1,043 956
1,007 1,144 727 1,203 1,104 1,129 868 920 975 978 851 771
651 569 481 680 574 530 263 254 268 241 228 191
651 569 481 1,050 910 923 731 612 763 735 790 719
124 297 21 32 95 108 45 226 34 106 23 19
70 42 16 9.2 8.6 8.7 10 10 14 12 11 10
492 – – – – – – – – – – –
124 127 123 123 127 107 112 113 113 113 113 113
2,336 2,514 2,221 2,250 2,239 2,184 1,369 1,299 1,337 1,304 1,188 1,146
1,469 1,635 804 1,158 1,181 1,154 422 389 430 460 342 331
1.3 5.1 6.3 9.4 9.7 7.0 5.5 5.6 5.0 2.5 2.1 4.1
102 133 58 80 58 42 34 51 15 25 16 23
168 168 168 169 169 170 170 171 244 244 291 291
-678 -717 -867 -432 -526 -624 -76 38 -157 -128 -145 -191
-4,643 -4,821 -4,969 -4,806 -4,927 -5,008 -4,490 -4,383 -4,586 -4,568 -4,578 -4,631
103 124 140 166 160 160 178 177 162 173 163 165

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?